Infinium Pharmachem Board of Directors

Get the latest insights into the leadership at Infinium Pharmachem. Learn about the experienced professionals guiding the company's strategy and governance.

NamePosition
Mr. Sanjaykumar Viththalbhai Patel Managing Director
Mr. Pravin Bhadabhai Madhani Executive Director
Mr. Mitesh Lavjibhai Chikhaliya Executive Director
Mr. Vaishakhi Ambrishbhai Shukla Independent Director
Mr. Tarun Ratilal Dobariya Independent Director
Mr. Keyur Jagdishchandra Shah Independent Director

Infinium Pharmachem Share price

INFINIUM

254.7

4.15 (1.66%)
NSE
BSE
Last updated on 4 Sep, 2025 | 15:21 IST
BUYSELL
Today's High

259.50

Today's Low

250.00

52 Week Low

182.45

52 Week High

392.50

The current prices are delayed, login to your account for live prices

Infinium Pharmachem FAQs

The board at Infinium Pharmachem consists of experienced professionals, including Mr. Sanjaykumar Viththalbhai Patel , Mr. Pravin Bhadabhai Madhani , and others, overseeing the company’s strategic and corporate governance.

Directors at Infinium Pharmachem are typically nominated by the Nomination and Remuneration Committee and approved by shareholders, adhering to regulatory and governance standards. While this is the standard procedure, the exact process may differ depending on the company’s internal policies and governance framework.

As of the latest update, Mr. Sanjaykumar Viththalbhai Patel is the current chairman at Infinium Pharmachem.

Executive directors at Infinium Pharmachem are involved in day-to-day operations, while non-executive directors, including independents, provide oversight and strategic input. While this distinction is generally followed, the specific responsibilities of executive and non-executive directors may vary based on the company’s organisational structure and governance practices.

Yes, Infinium Pharmachem adheres to all applicable SEBI and Companies Act provisions related to board structure, diversity, and independence.

At Infinium Pharmachem, board members usually serve fixed terms as outlined in the company’s charter or governance policy, commonly ranging between three to five years, with the possibility of renewal based on performance, shareholder approval, and regulatory norms.